Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision tag on the page now shows v3.6.6 instead of v3.6.5. This indicates a minor update to the study record's metadata/UI.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now displays a new revision version (v3.6.5) replacing the previous v3.6.4, indicating a recent update to the page's metadata. This change is a metadata update rather than a substantive modification to study details.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now shows an updated software revision tag, from v3.6.3 to v3.6.4, indicating a recent build update.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a small backend/template update.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a backend/template update to the page rather than changes to the study details.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page now communicates that recruitment has ended and provides additional guidance sections for readers and potential participants, accompanied by a small heading formatting change and a version update.SummaryDifference0.6%

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.